title: Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.
abstract: OBJECTIVE
  This study examined the treatment response of patients with first-episode schizophrenia and schizoaffective disorder and potential predictors of response.
  
  
  METHODS
  First-episode patients were assessed on measures of psychopathology, cognition, social functioning, and biological parameters and treated according to a standardized algorithm.
  
  
  RESULTS
  One hundred eighteen patients (52% male, mean age 25.2 years) entered the study. The cumulative percentage of patients responding by 1 year was 87%; the median time to response was 9 weeks. The following variables were significantly associated with less likelihood of response to treatment: male sex, obstetric complications, more severe hallucinations and delusions, poorer attention at baseline, and the development of parkinsonism during antipsychotic treatment. Variables not significantly related to treatment response were diagnosis (schizophrenia versus schizoaffective disorder), premorbid functioning, duration of psychotic symptoms prior to study entry, baseline disorganization, negative and depressive symptoms, baseline motor function, akathisia and dystonia during treatment, growth hormone and homovanillic acid measures, psychotic symptom activation to methylphenidate, and magnetic resonance measures.
  
  
  CONCLUSIONS
  Patients with first-episode schizophrenia and schizoaffective disorder have high rates of response to antipsychotic treatment; there are specific clinical and pathobiologic predictors of response.
authors: Department of Psychiatry, Hillside Hospital, Long Island Jewish Medical Center, New Hyde Park, N.Y., USA.
authors: D G
authors: DG
authors: Robinson
authors: M G
authors: MG
authors: Woerner
authors: J M
authors: JM
authors: Alvir
authors: S
authors: S
authors: Geisler
authors: A
authors: A
authors: Koreen
authors: B
authors: B
authors: Sheitman
authors: M
authors: M
authors: Chakos
authors: D
authors: D
authors: Mayerhoff
authors: R
authors: R
authors: Bilder
authors: R
authors: R
authors: Goldman
authors: J A
authors: JA
authors: Lieberman
mesh_terms: D000328:Adult; D000465:Algorithms; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D005260:Female; D006212:Hallucinations / Q000175:diagnosis / Q000453:epidemiology; D006801:Humans; D008297:Male; D015999:Multivariate Analysis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology; D011336:Probability; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D012720:Severity of Illness Index; D012737:Sex Factors; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents